Standard
Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial. / Van Gaal, L F; Caterson, I D; Coutinho, W; Finer, N; Maggioni, A P; Sharma, A M; Torp-Pedersen, C; Ge, Hongyou; Moran, S A; Shepherd, G M; James, W P T; SCOUT Investigators.
I:
Diabetes, Obesity and Metabolism, Bind 12, Nr. 1, 01.01.2010, s. 26-34.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Van Gaal, LF, Caterson, ID, Coutinho, W, Finer, N, Maggioni, AP, Sharma, AM
, Torp-Pedersen, C, Ge, H, Moran, SA, Shepherd, GM, James, WPT & SCOUT Investigators 2010, '
Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial',
Diabetes, Obesity and Metabolism, bind 12, nr. 1, s. 26-34.
https://doi.org/10.1111/j.1463-1326.2009.01090.xAPA
Van Gaal, L. F., Caterson, I. D., Coutinho, W., Finer, N., Maggioni, A. P., Sharma, A. M.
, Torp-Pedersen, C., Ge, H., Moran, S. A., Shepherd, G. M., James, W. P. T., & SCOUT Investigators (2010).
Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial.
Diabetes, Obesity and Metabolism,
12(1), 26-34.
https://doi.org/10.1111/j.1463-1326.2009.01090.xVancouver
Van Gaal LF, Caterson ID, Coutinho W, Finer N, Maggioni AP, Sharma AM o.a.
Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial.
Diabetes, Obesity and Metabolism. 2010 jan. 1;12(1):26-34.
https://doi.org/10.1111/j.1463-1326.2009.01090.xAuthor
Van Gaal, L F ; Caterson, I D ; Coutinho, W ; Finer, N ; Maggioni, A P ; Sharma, A M ; Torp-Pedersen, C ; Ge, Hongyou ; Moran, S A ; Shepherd, G M ; James, W P T ; SCOUT Investigators. / Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial. I: Diabetes, Obesity and Metabolism. 2010 ; Bind 12, Nr. 1. s. 26-34.
Bibtex
@article{b8dfac29a6384cd1928031b79aa6ec3e,
title = "Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial",
abstract = "To assess treatment responses to sibutramine and weight management in diabetic patients during the lead-in period of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial.",
author = "{Van Gaal}, {L F} and Caterson, {I D} and W Coutinho and N Finer and Maggioni, {A P} and Sharma, {A M} and C Torp-Pedersen and Hongyou Ge and Moran, {S A} and Shepherd, {G M} and James, {W P T} and Torp-Pedersen, {Christian Tobias}",
year = "2010",
month = jan,
day = "1",
doi = "http://dx.doi.org/10.1111/j.1463-1326.2009.01090.x",
language = "English",
volume = "12",
pages = "26--34",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "1",
}
RIS
TY - JOUR
T1 - Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial
AU - Van Gaal, L F
AU - Caterson, I D
AU - Coutinho, W
AU - Finer, N
AU - Maggioni, A P
AU - Sharma, A M
AU - Torp-Pedersen, C
AU - Ge, Hongyou
AU - Moran, S A
AU - Shepherd, G M
AU - James, W P T
AU - SCOUT Investigators
PY - 2010/1/1
Y1 - 2010/1/1
N2 - To assess treatment responses to sibutramine and weight management in diabetic patients during the lead-in period of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial.
AB - To assess treatment responses to sibutramine and weight management in diabetic patients during the lead-in period of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial.
U2 - http://dx.doi.org/10.1111/j.1463-1326.2009.01090.x
DO - http://dx.doi.org/10.1111/j.1463-1326.2009.01090.x
M3 - Journal article
VL - 12
SP - 26
EP - 34
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
SN - 1462-8902
IS - 1
ER -
